Immunization with Both T Cell-Dependent and T Cell-Independent Vaccines Augments HIV Viral Load Secondarily to Stimulation of Tumor Necrosis Factor α

No abstract is available for this paper.

• Publication year

  1998

• Venue

  AIDS Research and Human Retroviruses

• Publication date

  1998-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/aid.1998.14.727PMID 9643372
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of influenza vaccination in HIV-infected adults: a double-blind, placebo-controlled trial.

  1998cited by this paper
• Effect of influenza immunization on immunologic and virologic characteristics of pediatric patients infected with human immunodeficiency virus.

  1997cited by this paper
• Plasma viremia and virus phenotype are correlates of disease progression in vertically human immunodeficiency virus type 1-infected children.

  1997cited by this paper
• Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

  1997cited by this paper
• Increased plasma human immunodeficiency virus type 1 burden following antigenic challenge with pneumococcal vaccine.

  1996cited by this paper
• Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1.

  1996cited by this paper
• Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma

  1996cited by this paper
• T cell activation and human immunodeficiency virus replication after influenza immunization of infected children.

  1996cited by this paper
• Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS.

  1996cited by this paper
• Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA.

  1996cited by this paper
• Activation of virus replication after vaccination of HIV-1-infected individuals

  1995cited by this paper
• In vivo fate of HIV-1-infected T cells: Quantitative analysis of the transition to stable latency

  1995cited by this paper
• Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination.

  1995cited by this paper
• Influenza immunization of HIV-1-infected patients does not increase HIV-1 viral load.

  1994cited by this paper
• Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals.

  1993cited by this paper
• T cell-dependent B cell activation.

  1993cited by this paper
• HIV-1 viraemia and influenza.

  1992cited by this paper
• HIV-1 viraemia and influenza.

  1992cited by this paper
• The Effect of Cytokines and Pharmacologic Agents on Chronic HIV Infection

  1992cited by this paper
• Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1).

  1992cited by this paper
• Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection.

  1991cited by this paper
• Tumor necrosis factor-alpha/cachectin enhances human immunodeficiency virus type 1 replication in primary macrophages.

  1991cited by this paper
• Tumour necrosis factors (alpha, beta) induced by HIV-1 in peripheral blood mononuclear cells potentiate virus replication.

  1990cited by this paper
• HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure.

  1990cited by this paper
• Routine immunization of the HIV-positive asymptomatic patient

  1990cited by this paper
• Cellular interactions in the humoral immune response.

  1989cited by this paper
• Induction of expression of HIV in latently or chronically infected cells.

  1989cited by this paper
• Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat.

  1989cited by this paper
• Cytokines alter production of HIV-1 from primary mononuclear phagocytes.

  1988cited by this paper
• Long-term cultures of HTLV-III--infected T cells: a model of cytopathology of T-cell depletion in AIDS.

  1986cited by this paper
• Susceptibility of normal human lymphocytes to infection with HTLV-III/LAV.

  1986cited by this paper
• The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

  1984influential reference
• T Cell‐Dependent B Cell Activation

  1984cited by this paper

• Impact of influenza and pneumococcal vaccines on HIV persistence and immune dynamics during suppressive antiretroviral therapy

  2024cites this paper
• Unexpectedly higher levels of anti-orthopoxvirus neutralizing antibodies are observed among gay men than general adult population

  2023cites this paper
• SARS-CoV-2 mRNA vaccines induce greater complement activation and decreased viremia and Nef antibodies in men with HIV-1.

  2023cites this paper
• Fourth Dose of mRNA COVID-19 Vaccine Transiently Reactivates Spike-Specific Immunological Memory in People Living with HIV (PLWH)

  2022cites this paper
• Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine in people living with HIV-1

  2021cites this paper
• Transient increase in plasma HIV RNA after COVID-19 vaccination with mRNA-1272

  2021cites this paper
• Immunogenicity of an inactivated SARS-CoV-2 vaccine in people living with HIV-1: a non-randomized cohort study

  2021cites this paper
• Decreased ratio of influenza-specific IgG versus IgM in response to influenza vaccination in antiretroviral-treated HIV-infected African Americans compared to Caucasians, and its direct correlation with the percentages of peripheral Tfh cells.

  2020cites this paper
• Cytomegalovirus Viremia in Renal Transplant Recipients After Influenza Vaccination

  2020cites this paper
• 47 – Pneumococcal Polysaccharide Vaccines

  2018cites this paper
• Influenza Vaccination Can Broadly Activate the HIV Reservoir During Antiretroviral Therapy

  2018cites this paper
• The induction of CD80 and apoptosis on B cells and CD40L in CD4+ T cells in response to seasonal influenza vaccination distinguishes responders versus non-responders in healthy controls and aviremic ART-treated HIV-infected individuals.

  2017cites this paper
• Standard vaccines increase HIV-1 transcription during antiretroviral therapy

  2016cites this paper
• Key differences in B cell activation patterns and immune correlates among treated HIV-infected patients versus healthy controls following influenza vaccination.

  2016cites this paper
• Influenza vaccination for immunocompromised patients: systematic review and meta-analysis by etiology.

  2012cites this paper
• Were the interests of the vulnerable truly served? The predictable failure of HIVIG.

  2012cites this paper
• Influenza Vaccination for Immunocompromised Patients: Systematic Review and Meta-Analysis from a Public Health Policy Perspective

  2011cites this paper
• Adverse reactions of trivalent influenza vaccine in HIV-infected individuals.

  2010cites this paper
• Effect of treating co-infections on HIV-1 viral load: a systematic review.

  2010cites this paper
• Pneumococcal polysaccharide vaccines

  2008cites this paper
• FIV vaccine development: a continuing challenge

  2008cites this paper
• Vaccine-induced enhancement of viral infections

  2008cites this paper
• Efficacy and clinical effectiveness of influenza vaccines in HIV-infected individuals: a meta-analysis

  2006cites this paper
• Immunogenicity and effect of a virosomal influenza vaccine on viral replication and T‐cell activation in HIV‐infected children receiving highly active antiretroviral therapy

  2006cites this paper
• Actualización en la vacunación del adulto

  2004cites this paper
• Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and pneumonia with consolidation on x-ray in children under two years of age.

  2004cites this paper
• [Adult vaccination update].

  2004cites this paper
• Immunogenicity and efficacy of childhood vaccines in HIV-1-infected children.

  2004cites this paper
• Chapter 38 – Immunizations, Vaccine-Preventable Diseases, and HIV Infection

  2003cites this paper
• [Influenza immunization risks in HIV infected children].

  2003cites this paper
• Riscos da vacinação antiinfluenza em crianças com infecção pelo HIV Influenza immunization risks in HIV infected children

  2003cites this paper
• Viral load response to a pneumococcal conjugate vaccine, polysaccharide vaccine or placebo among HIV-infected patients.

  2002cites this paper
• Randomized, Placebo-Controlled Trial of Product R, a Peptide-Nucleic Acid Immunomodulator, in the Treatment of Adults Infected with HIV

  2002cites this paper
• Recombinant Glycoprotein Vaccines for Human Immunodeficiency Virus-Infected Children and Their Effects on Viral Quasispecies

  2002cites this paper
• Influenza A among patients with human immunodeficiency virus: an outbreak of infection at a residential facility in New York City.

  2001cites this paper
• Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination.

  2001cites this paper
• Cytokine and chemokine based control of HIV infection and replication.

  2001cites this paper
• Immunologic and virologic evaluation of HIV-1-infected children after rabies vaccination.

  2001cites this paper
• Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy.

  2000cites this paper
• Influenza and its vaccination in HIV1-AIDS patients.

  2000cites this paper
• Effect of vitamin A therapy on serologic responses and viral load changes after influenza vaccination in children infected with the human immunodeficiency virus.

  2000cites this paper
• Progressive specific immune attrition after primary, secondary and tertiary immunizations with bacteriophage ΦX174 in asymptomatic HIV-1 infected patients

  2000cites this paper
• Reduction of the HIV-1-infected T-cell reservoir by immune activation treatment is dose-dependent and restricted by the potency of antiretroviral drugs

  2000cites this paper
• Pneumococcal and influenza immunization and human immunodeficiency virus load in children

  2000influential citation
• Influenza, influenza virus vaccine, and human immunodeficiency virus infection.

  1999cites this paper
• Editorial Response: Influenza, Influenza Virus Vaccine, and Human Immunodeficiency Virus Infection

  1999cites this paper
• Immune activation in HIV‐infected African individuals

  1998cites this paper
• Immune activation in HIV-infected African individuals. Italian-Ugandan AIDS cooperation program.

  1998cites this paper
• Progressive speci®c immune attrition after primary, secondary and tertiary immunizations with bacteriophage ÖX174 in asymptomatic HIV-1 infected patients

  year unknowncites this paper